limestone has been researched along with CKD-MBD in 65 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 20 (30.77) | 18.7374 |
1990's | 27 (41.54) | 18.2507 |
2000's | 15 (23.08) | 29.6817 |
2010's | 3 (4.62) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Alonso, M; Andrés, E; Ballarín, J; Bover, J; Canal, C; Farré, N; Olaya, MT; Quílez, B | 1 |
Craig, JC; Elder, GJ; Navaneethan, SD; Palmer, SC; Strippoli, GF | 1 |
Elashoff, R; Gales, B; Jüppner, H; Pereira, RC; Sahney, S; Salusky, IB; Wang, HJ; Wesseling-Perry, K | 1 |
Bondor, C; Brumboiu, A; Gherman-Caprioara, M; Kacso, I; Moldovan, D; Moldovan, I; Orasan, R; Parvu, L; Patiu, IM; Racasan, S; Rusu, C | 1 |
Jean, G | 1 |
Bijak, K; Bogdańska-Straszyńska, B; Matuszkiewicz-Rowińska, J; Małecka, G; Ostrowski, K; Przedlacki, J; Trebicka, J | 1 |
Balducci, A; Coen, G; Curic, S; D'Haese, PC; De Broe, ME; Dimkovic, N; Djukanovic, L; Ferreira, A; Freemont, TJ; Hutchison, A; Pejanovic, S; Popovic, M; Sikole, A; Spasovski, GB; Sulkova, S; Sulowicz, W; Swanepoel, C; Torres, A | 1 |
Hoshino, J; Takaichi, K; Ubara, Y | 1 |
Freemont, T; Malluche, HH | 1 |
Benador, N; Greenbaum, LA; Grenda, R; Melnick, JZ; Paredes, A; Qiu, P; Restaino, I; Salusky, IB; Williams, LA; Wojtak, A | 1 |
Kinugasa, E; Koiwa, F; Ogata, H; Shishido, K | 1 |
Yumita, S | 1 |
Davies, MR; Hruska, KA; Lund, RJ; Mathew, S | 1 |
Denton, J; Freemont, AJ; Hoyland, JA | 1 |
Abu-Alfa, AK; Brewster, UC; Ciampi, MA; Reilly, RF | 1 |
Bellinghieri, G; Calò, LA; Monardo, P; Santoro, D; Savica, V | 1 |
Baldaia, J; Duggal, A; Ferreira, A; Frazão, JM; Galvao, J; Gil, C; Hoenger, RM; Malluche, HH; Monier-Faugere, MC; Oliveira, C; Ribeiro, S; Rodrigues, I; Santos, C | 1 |
Mehls, O; Ritz, E | 1 |
Dewar, J; Ellis, HA; Gokal, R; Kerr, DN; Parkinson, I; Ramos, JM; Sweetman, V; Ward, MK | 1 |
Barzel, US | 1 |
Concepcion, MT; De Bonis, E; Felsenfeld, AJ; Gonzalez-Posada, JM; Hernandez, D; Lorenzo, V; Martinez, ME; Rodriguez, A; Rodriguez, M; Torres, A | 1 |
Fournier, A | 1 |
Fenton, S; Greenwood, C; Hercz, G; Manuel, A; Pei, Y; Saiphoo, C; Segre, G; Sherrard, D | 1 |
Bianchi, ML; Buccianti, G; Campanini, F; Colantonio, G; Ortolani, S; Rossi, R; Valenti, G | 1 |
Passlick-Deetjen, J; Ritz, E; Weinreich, T | 1 |
Dal Zotto, M; Dalla Fini, G; Ragazzi, E; Realdon, N | 1 |
Carozzi, S; Nasini, MG; Pietrucci, A; Santoni, O | 1 |
Brown, A; Freeman, J; Johnson, DW; McIntyre, HD; Rigby, RJ | 1 |
Adu, D; Bhalla, C; Cochrane, T; Duncan, R; Michael, J; Richards, NT | 1 |
Roszkowska-Blaim, M; Sieniawska, M; Wojciechowska, B | 1 |
Corradi, B; Imbasciati, E; Malberti, F | 1 |
Hayakawa, H; Kato, N; Kawaguchi, Y; Kubo, H; Nakayama, M; Ogawa, A; Osaka, N; Sakai, O; Shigematsu, T; Yamamoto, H | 1 |
Akil, R; Baudouin, V; Loirat, C; Macher, MA | 1 |
Franson, KL; Kuk, JM; Lau, AH | 1 |
Abighanem, O; Achard, JM; Atik, A; Boudailliez, B; El Esper, N; Fournier, A; Ghazali, A; Hedri, H; Hottelart, C; Moriniere, P; Oprisiu, R; Pruna, A; Rasolombololona, M; Said, S; Sarraj, A; Sechet, A; Westeel, PF; Yverneau, PH | 1 |
Kessler, M | 1 |
Fukagawa, M | 1 |
Arsenescu, I; Benamar, L; el Esper, N; Fournier, A; Ghitu, S; Morinière, P; Oprisiu, R; Said, S; Tataru Albu, A | 1 |
Flury, W; Haldimann, B | 1 |
Arnaud, CD; Bordier, PJ; Marie, PJ | 1 |
Drivas, G; Kerr, D; Ward, M | 1 |
Boulton, HF; Freemont, AJ; Gokal, R; Hutchison, AJ | 1 |
Groshong, T; Lal, SM | 1 |
Gunn, A; Henderson, IS; Mactier, RA; Stewart, WK; Taylor, J | 1 |
Schaefer, K; Umlauf, E; von Herrath, D | 1 |
Fitzrandolph, RL; Molpus, WM; Pritchard, RS; Walker, CW | 1 |
Gladziwa, U; Ittel, TH; Schäfer, C; Schmitt, H; Sieberth, HG | 1 |
Achard, JM; Amar, M; Boudailliez, B; Djerad, M; Fournier, A; Morinière, P; Nahle, M; Westeel, PF | 1 |
Brodehl, J; Hoyer, PF; Jüppner, H; Latta, K; Offner, G; Winkler, L | 1 |
Hisano, S; Kawagoe, M; Ueda, K; Yamane, I | 1 |
Barsotti, G; Giovannetti, S; Gretz, N; Kraft, K | 1 |
Belbrik, S; Boudailliez, B; Fournier, A; Hocine, C; Marie, A; Morinière, P; Renaud, M; Sebert, JL; Westeel, PF | 1 |
Belbrik, S; Fournier, A; Hocine, C; Idrissi, A; Leflon, P; Marie, A; Morinière, P; Renaud, H; Sebert, JL; Westeel, PF | 1 |
Belbrik, S; Boudaillez, B; Fournier, A; Hocine, C; Marie, A; Moriniere, P; Renaud, H; Westeel, PF | 1 |
Fournier, A; Garabedian, M; Gueris, J; Idrissi, A; Renaud, H; Sebert, JL; Westeel, PF | 1 |
Hatano, M; Kuno, T; Maeda, H; Okada, K; Takahashi, S; Yanai, M | 1 |
Andress, DL; Coburn, JW; Hercz, G; Nebeker, HG; Sherrard, DJ; Shinaberger, JH | 1 |
Chantler, C; Compston, J; Haycock, GB; Mak, RH; Mellish, RW; Turner, C; Vedi, S | 1 |
Slatopolsky, E | 1 |
Delmez, J; Slatopolsky, E; Stokes, T; Weerts, C; Windus, D | 1 |
Audet, P; Fallon, MD; Kaplan, F; Morrison, G; Shusterman, NH; Wasserstein, AG | 1 |
Blockey, NJ; Mocan, H; Murphy, AV | 1 |
Brickman, AS; Norman, AW | 1 |
deVeber, GA; Fenton, SS; Meema, HE; Murray, T; Oreopoulos, DG; Rabinovich, S; Taves, DR | 1 |
Marsac, J; Meyrier, A; Richet, G | 1 |
15 review(s) available for limestone and CKD-MBD
Article | Year |
---|---|
Update on the treatment of chronic kidney disease-mineral and bone disorder.
Topics: Aluminum Compounds; Calcinosis; Calcium Carbonate; Chelating Agents; Chronic Kidney Disease-Mineral and Bone Disorder; Cinacalcet; Diet, Protein-Restricted; Dietetics; Humans; Kidney Failure, Chronic; Lanthanum; Naphthalenes; Nephrology; Nutrition Assessment; Nutritive Value; Parathyroidectomy; Patient Care Team; Patient Education as Topic; Phosphorus; Polyamines; Practice Guidelines as Topic; Sevelamer; Vitamin D | 2009 |
Benefits and harms of phosphate binders in CKD: a systematic review of randomized controlled trials.
Topics: Acetates; Biomarkers; Bone Density Conservation Agents; Calcium; Calcium Carbonate; Calcium Compounds; Chelating Agents; Chronic Kidney Disease-Mineral and Bone Disorder; Humans; Hypercalcemia; Hyperphosphatemia; Lanthanum; Parathyroid Hormone; Phosphates; Phosphorus; Polyamines; Randomized Controlled Trials as Topic; Renal Insufficiency, Chronic; Research Design; Sevelamer | 2009 |
[How to manage mineral metabolism disorders in renal failure].
Topics: Aged; Alkaline Phosphatase; Bone Density; Calcimimetic Agents; Calcitriol; Calcium Carbonate; Chelating Agents; Chronic Kidney Disease-Mineral and Bone Disorder; Combined Modality Therapy; Diabetic Nephropathies; Female; Humans; Hyperparathyroidism, Secondary; Hyperphosphatemia; Kidney Failure, Chronic; Male; Parathyroid Hormone; Phosphorus, Dietary; Predictive Value of Tests; Renal Replacement Therapy | 2011 |
[Clinical evidence and treatment for optimum concentration of parathyroid hormone, calcium and phosphate in chronic renal failure].
Topics: Calcinosis; Calcium; Calcium Carbonate; Calcium, Dietary; Chronic Kidney Disease-Mineral and Bone Disorder; Epoxy Compounds; Evidence-Based Medicine; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Parathyroid Hormone; Phosphorus; Phosphorus, Dietary; Polyamines; Polyethylenes; Practice Guidelines as Topic; Sevelamer | 2004 |
Phosphate binders and management of hyperphosphataemia in end-stage renal disease.
Topics: Acetates; Aluminum Compounds; Bone Diseases, Metabolic; Calcinosis; Calcium Carbonate; Calcium Compounds; Cardiovascular Diseases; Central Nervous System Diseases; Chronic Kidney Disease-Mineral and Bone Disorder; Diet, Protein-Restricted; Ferric Compounds; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Lanthanum; Phosphates; Phosphorus, Dietary; Polyamines; Renal Dialysis; Sevelamer | 2006 |
[Current treatment of renal osteodystrophy in children].
Topics: Calcium Carbonate; Child; Chronic Kidney Disease-Mineral and Bone Disorder; Growth Hormone; Humans; Vitamin D | 1997 |
Renal osteodystrophy in dialysis patients: diagnosis and treatment.
Topics: Adult; Alkaline Phosphatase; Aluminum; Bicarbonates; Biopsy; Calcifediol; Calcium; Calcium Carbonate; Child; Chronic Kidney Disease-Mineral and Bone Disorder; Dialysis Solutions; Fibrous Dysplasia of Bone; Humans; Hydroxycholecalciferols; Hypercalcemia; Hyperparathyroidism; Hypoparathyroidism; Osteomalacia; Parathyroid Hormone; Parathyroidectomy; Phosphates; Phosphorus; Radiography; Renal Dialysis; Vitamin D Deficiency | 1998 |
[Chronic renal failure: etiology, physiopathology, diagnosis, principles of the treatment].
Topics: Adolescent; Adult; Age Factors; Antihypertensive Agents; Calcium Carbonate; Child; Child, Preschool; Chronic Kidney Disease-Mineral and Bone Disorder; Creatinine; Diagnosis, Differential; Diet; Female; Humans; Infant; Infant, Newborn; Kidney Failure, Chronic; Kidney Function Tests; Kidney Transplantation; Male; Peritoneal Dialysis; Renal Dialysis; Sex Factors; Water-Electrolyte Balance | 1998 |
[Physiopathology and therapy of renal osteodystrophy and secondary hyperparathyroidism].
Topics: Animals; Calcium Carbonate; Chronic Kidney Disease-Mineral and Bone Disorder; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Parathyroid Hormone; Parathyroidectomy; Receptors, Calcitriol; Vitamin D | 1999 |
[Renal osteodystrophy (3); its treatment in dialysis patients].
Topics: Aluminum; Calcium Carbonate; Chelating Agents; Chronic Kidney Disease-Mineral and Bone Disorder; Deferoxamine; Humans; Hyperparathyroidism; Osteomalacia; Parathyroidectomy; Renal Dialysis; Vitamin D | 2000 |
The radiographic spectrum of renal osteodystrophy.
Topics: Aluminum Hydroxide; Calcium; Calcium Carbonate; Chronic Kidney Disease-Mineral and Bone Disorder; Humans; Kidney Failure, Chronic; Phosphates; Radiography | 1991 |
[Role of calcium carbonate in the treatment of renal osteodystrophy].
Topics: Adult; Calcium Carbonate; Chelating Agents; Child; Chronic Kidney Disease-Mineral and Bone Disorder; Humans; Phosphates; Renal Dialysis | 1991 |
Calcium carbonate and magnesium hydroxide in the prevention of renal osteodystrophy or the demise of aluminum toxicity in uremia. Analysis of 5 years experience.
Topics: Adult; Aluminum; Calcium Carbonate; Child; Chronic Kidney Disease-Mineral and Bone Disorder; Humans; Magnesium; Magnesium Hydroxide; Phosphates; Renal Dialysis; Uremia | 1988 |
1,25 (OH)2 vitamin D3 deficiency and renal osteodystrophy: should its well-accepted pathogenetic role in secondary hyperparathyroidism lead to its systematic preventive therapeutic use?
Topics: Calcitriol; Calcium Carbonate; Chronic Kidney Disease-Mineral and Bone Disorder; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Vitamin D Deficiency | 1987 |
Treatment of renal osteodystrophy with calciferol (vitamin D) and related steroids.
Topics: Aluminum; Bone Regeneration; Calcium; Calcium Carbonate; Cholecalciferol; Chronic Kidney Disease-Mineral and Bone Disorder; Dihydrotachysterol; Dihydroxycholecalciferols; Ergocalciferols; Humans; Hydroxycholecalciferols; Intestinal Absorption; Osteitis Fibrosa Cystica; Osteomalacia; Parathyroid Glands; Phosphorus; Secretory Rate; Vitamin D | 1973 |
12 trial(s) available for limestone and CKD-MBD
Article | Year |
---|---|
Calcitriol and doxercalciferol are equivalent in controlling bone turnover, suppressing parathyroid hormone, and increasing fibroblast growth factor-23 in secondary hyperparathyroidism.
Topics: Adolescent; Bone and Bones; Bone Density Conservation Agents; Calcitriol; Calcium Carbonate; Chronic Kidney Disease-Mineral and Bone Disorder; Drug Therapy, Combination; Ergocalciferols; Female; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Hyperphosphatemia; Kidney Failure, Chronic; Longitudinal Studies; Male; Osteogenesis; Parathyroid Hormone; Polyamines; Sevelamer | 2011 |
A multicenter study on the effects of lanthanum carbonate (Fosrenol) and calcium carbonate on renal bone disease in dialysis patients.
Topics: Adult; Aged; Biomarkers; Bone and Bones; Calcium Carbonate; Chronic Kidney Disease-Mineral and Bone Disorder; Female; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Lanthanum; Male; Middle Aged; Phosphates; Renal Dialysis | 2003 |
Intravenous calcitriol for treatment of hyperparathyroidism in children on hemodialysis.
Topics: Acetates; Adolescent; Calcitriol; Calcium; Calcium Carbonate; Calcium Channel Agonists; Calcium Compounds; Child; Child, Preschool; Chronic Kidney Disease-Mineral and Bone Disorder; Female; Humans; Hyperparathyroidism, Secondary; Injections, Intravenous; Kidney Failure, Chronic; Male; Parathyroid Hormone; Phosphates; Renal Dialysis | 2005 |
[Sevelamer hydrochloride and K/DOQI guidelines].
Topics: Alkaline Phosphatase; Calcium; Calcium Carbonate; Cholecalciferol; Chronic Kidney Disease-Mineral and Bone Disorder; Dialysis; Drug Therapy, Combination; Female; Humans; Hyperparathyroidism, Secondary; Male; Parathyroid Hormone; Phosphorus; Polyamines; Practice Guidelines as Topic; Sevelamer | 2005 |
The effects of lanthanum carbonate and calcium carbonate on bone abnormalities in patients with end-stage renal disease.
Topics: Adult; Aged; Aged, 80 and over; Biopsy; Calcitriol; Calcium; Calcium Carbonate; Chronic Kidney Disease-Mineral and Bone Disorder; Female; Humans; Kidney Failure, Chronic; Lanthanum; Male; Phosphorus; Renal Dialysis; Treatment Outcome | 2005 |
Effects of sevelamer hydrochloride and calcium carbonate on renal osteodystrophy in hemodialysis patients.
Topics: Adult; Aged; Antacids; Biopsy; Calcification, Physiologic; Calcium; Calcium Carbonate; Chelating Agents; Chronic Kidney Disease-Mineral and Bone Disorder; Female; Humans; Ilium; Kidney Failure, Chronic; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Polyamines; Renal Dialysis; Sevelamer; Treatment Outcome | 2008 |
Low dialysate calcium in continuous ambulatory peritoneal dialysis: a randomized controlled multicenter trial. The Peritoneal Dialysis Multicenter Study Group.
Topics: Alkaline Phosphatase; Aluminum Hydroxide; Bone Density; Calcitriol; Calcium; Calcium Carbonate; Chronic Kidney Disease-Mineral and Bone Disorder; Dialysis Solutions; Female; Humans; Hypercalcemia; Kidney Failure, Chronic; Male; Middle Aged; Osteocalcin; Parathyroid Hormone; Peritoneal Dialysis, Continuous Ambulatory; Phosphates; Prospective Studies; Time Factors | 1995 |
A randomized trial comparing 1.25 mmol/l calcium dialysate to 1.75 mmol/l calcium dialysate in CAPD patients.
Topics: Aluminum Hydroxide; Bone Density; Calcitriol; Calcium Carbonate; Chronic Kidney Disease-Mineral and Bone Disorder; Dialysis Solutions; Double-Blind Method; Female; Follow-Up Studies; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Male; Middle Aged; Osteocalcin; Parathyroid Hormone; Peritoneal Dialysis, Continuous Ambulatory; Phosphates; Prospective Studies | 1996 |
Phosphate-binding capacities of calcium and aluminum formulations.
Topics: Acetates; Administration, Oral; Adult; Aluminum Compounds; Calcium Carbonate; Calcium Phosphates; Chronic Kidney Disease-Mineral and Bone Disorder; Drug Monitoring; Female; Gels; Humans; Intestinal Absorption; Kidney Failure, Chronic; Male; Phosphates; Suspensions; Tablets | 1998 |
Low-calcium dialysis fluid and oral calcium carbonate in CAPD. A method of controlling hyperphosphataemia whilst minimizing aluminium exposure and hypercalcaemia.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aluminum; Bicarbonates; Bone and Bones; Calcium; Calcium Carbonate; Calcium, Dietary; Chronic Kidney Disease-Mineral and Bone Disorder; Dialysis Solutions; Female; Humans; Hypercalcemia; Male; Middle Aged; Parathyroid Hormone; Peritoneal Dialysis, Continuous Ambulatory; Phosphates; Prospective Studies | 1992 |
Calcium carbonate as a phosphate binder in dialysis patients: evaluation of an enteric-coated preparation and effect of additional aluminium hydroxide on hyperaluminaemia.
Topics: Aluminum; Aluminum Hydroxide; Calcium; Calcium Carbonate; Chronic Kidney Disease-Mineral and Bone Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Humans; Hypercalcemia; Kidney Failure, Chronic; Kidney Function Tests; Parathyroid Hormone; Phosphates; Prospective Studies; Renal Dialysis; Tablets | 1991 |
Fluoride and dialysis osteodystrophy: results of a double-blind study.
Topics: Alkaline Phosphatase; Aluminum Hydroxide; Calcium; Calcium Carbonate; Chronic Kidney Disease-Mineral and Bone Disorder; Clinical Trials as Topic; Creatinine; Female; Fluorides; Humans; Male; Osteomalacia; Parathyroid Hormone; Phosphorus; Quebec; Radiography; Renal Dialysis; Water Supply | 1974 |
38 other study(ies) available for limestone and CKD-MBD
Article | Year |
---|---|
Vascular calcifications and renal osteodystrophy in chronic hemodialysis patients: what is the relationship between them?
Topics: Acetates; Adult; Aged; Aged, 80 and over; Bone Density Conservation Agents; Calcium; Calcium Carbonate; Calcium Compounds; Chronic Kidney Disease-Mineral and Bone Disorder; Female; Humans; Linear Models; Logistic Models; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Radiography; Renal Dialysis; Risk Factors; Serum Albumin; Sex Factors; Vascular Calcification | 2011 |
Cross-linked C-terminal telopeptide of type I collagen in serum before and after treatment with alfacalcidol and calcium carbonate in early and moderate chronic renal failure.
Topics: Adult; Aged; Biomarkers; Bone Resorption; Calcium Carbonate; Chronic Kidney Disease-Mineral and Bone Disorder; Collagen; Collagen Type I; Female; Humans; Hydroxycholecalciferols; Kidney Failure, Chronic; Male; Middle Aged; Parathyroid Hormone; Peptides | 2002 |
Utilization of bone histomorphometry in renal osteodystrophy: demonstration of a new approach using data from a prospective study of lanthanum carbonate.
Topics: Adult; Bone Remodeling; Calcification, Physiologic; Calcium Carbonate; Chronic Kidney Disease-Mineral and Bone Disorder; Female; Histological Techniques; Humans; Ilium; Lanthanum; Male; Osteocytes; Prospective Studies | 2005 |
Combination therapy with sevelamer hydrochloride and calcium carbonate in Japanese patients with long-term hemodialysis: alternative approach for optimal mineral management.
Topics: Antacids; Bone and Bones; Bone Density; Calcium; Calcium Carbonate; Calcium, Dietary; Chronic Kidney Disease-Mineral and Bone Disorder; Drug Therapy, Combination; Epoxy Compounds; Humans; Hyperparathyroidism, Secondary; Japan; Kidney Failure, Chronic; Parathyroid Hormone; Phosphorus; Polyamines; Polyethylenes; Renal Dialysis; Sevelamer; Time Factors | 2005 |
Connections between vascular calcification and progression of chronic kidney disease: therapeutic alternatives.
Topics: Animals; Aorta, Thoracic; Bone Diseases; Bone Morphogenetic Protein 7; Bone Morphogenetic Proteins; Calcinosis; Calcium; Calcium Carbonate; Chronic Disease; Chronic Kidney Disease-Mineral and Bone Disorder; Dietary Fats; Disease Progression; Female; Hyperparathyroidism; Kidney Diseases; Male; Mice; Mice, Inbred C57BL; Osteoblasts; Osteogenesis; Phosphates; Renal Insufficiency, Chronic; Transforming Growth Factor beta | 2005 |
Long-term comparison of sevelamer hydrochloride to calcium-containing phosphate binders.
Topics: Acetates; Bicarbonates; Calcium; Calcium Carbonate; Calcium Compounds; Chronic Kidney Disease-Mineral and Bone Disorder; Drug Combinations; Female; Humans; Hypophosphatemia; Kidney Failure, Chronic; Magnesium; Male; Middle Aged; Phosphates; Phosphorus; Polyamines; Renal Dialysis; Retrospective Studies; Sevelamer | 2006 |
Early treatment of renal osteodystrophy.
Topics: Calcitriol; Calcium; Calcium Carbonate; Carrier Proteins; Chronic Kidney Disease-Mineral and Bone Disorder; Glomerular Filtration Rate; Humans; Hypocalcemia; Kidney Failure, Chronic; Parathyroid Hormone; Phosphate-Binding Proteins; Phosphates | 1984 |
Histological renal osteodystrophy, and 25 hydroxycholecalciferol and aluminum levels in patients on continuous ambulatory peritoneal dialysis.
Topics: Adolescent; Adult; Aged; Alkaline Phosphatase; Aluminum; Biopsy; Calcifediol; Calcium; Calcium Carbonate; Child; Child, Preschool; Chronic Kidney Disease-Mineral and Bone Disorder; Female; Humans; Ilium; Male; Middle Aged; Parathyroid Glands; Parathyroid Hormone; Peritoneal Dialysis; Peritoneal Dialysis, Continuous Ambulatory; Time Factors | 1983 |
Renal osteodystrophy.
Topics: Acetates; Acetic Acid; Acidosis; Antacids; Calcium Carbonate; Chronic Kidney Disease-Mineral and Bone Disorder; Diet; Humans; Phosphates | 1995 |
Adynamic bone disease with negative aluminium staining in predialysis patients: prevalence and evolution after maintenance dialysis.
Topics: Adult; Aluminum; Bone and Bones; Calcium Carbonate; Chronic Kidney Disease-Mineral and Bone Disorder; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Parathyroid Hormone; Prospective Studies; Renal Dialysis; Staining and Labeling | 1994 |
Calcitriol and calcium carbonate therapy in early chronic renal failure.
Topics: Calcitriol; Calcium Carbonate; Chronic Kidney Disease-Mineral and Bone Disorder; Drug Therapy, Combination; Humans; Kidney Failure, Chronic | 1995 |
Risk factors for renal osteodystrophy: a multivariant analysis.
Topics: Adult; Aged; Aging; Aluminum; Analysis of Variance; Calcium Carbonate; Canada; Chronic Kidney Disease-Mineral and Bone Disorder; Diabetes Complications; Female; Follow-Up Studies; Humans; Longitudinal Studies; Male; Middle Aged; Odds Ratio; Peritoneal Dialysis; Prospective Studies; Renal Dialysis; Risk Assessment; Risk Factors; Sex Factors | 1995 |
Calcitriol and calcium carbonate therapy in early chronic renal failure.
Topics: Adult; Alkaline Phosphatase; Bone Density; Calcification, Physiologic; Calcitriol; Calcium; Calcium Carbonate; Chronic Kidney Disease-Mineral and Bone Disorder; Drug Therapy, Combination; Female; Humans; Hydroxyproline; Kidney Failure, Chronic; Kidney Function Tests; Male; Middle Aged; Osteocalcin; Parathyroid Hormone | 1994 |
Technological testing of calcium carbonate tablets for use in the treatment of renal osteodystrophy.
Topics: Calcium Carbonate; Chronic Kidney Disease-Mineral and Bone Disorder; Hardness Tests; Humans; Hydrogen-Ion Concentration; Particle Size; Phosphorus; Quality Control; Solubility; Tablets | 1993 |
Low- and high-turnover bone disease in continuous ambulatory peritoneal dialysis: effects of low-Ca2+ peritoneal dialysis solution.
Topics: Administration, Oral; Aluminum; Calcium; Calcium Carbonate; Chronic Kidney Disease-Mineral and Bone Disorder; Dialysis Solutions; Female; Humans; Male; Middle Aged; Parathyroid Hormone; Peritoneal Dialysis, Continuous Ambulatory; Phosphates; Retrospective Studies | 1993 |
Low calcium dialysate and hyperparathyroidism.
Topics: Adult; Aged; Alkaline Phosphatase; Calcium; Calcium Carbonate; Chronic Kidney Disease-Mineral and Bone Disorder; Combined Modality Therapy; Dialysis Solutions; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Middle Aged; Parathyroid Hormone; Parathyroidectomy; Peritoneal Dialysis, Continuous Ambulatory; Phosphates; Prospective Studies; Risk Factors | 1996 |
The influence of dialysate calcium concentration on the PTH level in children undergoing CAPD.
Topics: Adolescent; Calcium; Calcium Carbonate; Child; Child, Preschool; Chronic Kidney Disease-Mineral and Bone Disorder; Dialysis Solutions; Female; Humans; Kidney Failure, Chronic; Male; Parathyroid Hormone; Peritoneal Dialysis, Continuous Ambulatory; Ultrafiltration | 1996 |
Effect of CAPD and hemodialysis on parathyroid function.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biopsy; Bone and Bones; Calcium; Calcium Carbonate; Chronic Kidney Disease-Mineral and Bone Disorder; Female; Follow-Up Studies; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Middle Aged; Parathyroid Glands; Parathyroid Hormone; Peritoneal Dialysis, Continuous Ambulatory; Phosphates; Renal Dialysis | 1996 |
Low calcium (1.25 mmol/L) dialysate can normalize relative hypoparathyroidism in CAPD patients with low bone turnover.
Topics: Aged; Alkaline Phosphatase; Calcium; Calcium Carbonate; Chronic Kidney Disease-Mineral and Bone Disorder; Dialysis Solutions; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Hypercalcemia; Hypoparathyroidism; Male; Middle Aged; Osteocalcin; Parathyroid Hormone; Peritoneal Dialysis, Continuous Ambulatory; Phosphates | 1996 |
[Treatment of renal osteodystrophy: physiopathology and secondary effects].
Topics: Aluminum Hydroxide; Calcium Carbonate; Chronic Kidney Disease-Mineral and Bone Disorder; Constipation; Female; Humans; Kidney Transplantation; Male; Middle Aged; Transplantation, Homologous; Vitamin D | 1977 |
Evolution of renal osteodystrophy: correlation of bone histomorphometry and serum mineral and immunoreactive parathyroid hormone values before and after treatment with calcium carbonate or 25-hydroxycholecalciferol.
Topics: Adolescent; Adult; Aged; Bone and Bones; Bone Development; Bone Resorption; Calcification, Physiologic; Calcium; Calcium Carbonate; Chronic Kidney Disease-Mineral and Bone Disorder; Creatinine; Female; Humans; Hydroxycholecalciferols; Male; Middle Aged; Minerals; Osteoclasts; Osteocytes; Osteolysis; Parathyroid Hormone; Phosphates; Radioimmunoassay; Vitamin D | 1975 |
Immobilization hypercalcaemia in patients on regular haemodialysis.
Topics: Adult; Calcium Carbonate; Chronic Kidney Disease-Mineral and Bone Disorder; Dihydrotachysterol; Female; Humans; Hypercalcemia; Immobilization; Male; Middle Aged; Renal Dialysis | 1975 |
Is calcium carbonate a safe phosphate binder in children with chronic renal failure?
Topics: Adolescent; Calcium; Calcium Carbonate; Child; Child, Preschool; Chronic Kidney Disease-Mineral and Bone Disorder; Dialysis Solutions; Humans; Hypercalcemia; Kidney Failure, Chronic; Male; Peritoneal Dialysis | 1992 |
Parathyroidectomy in uraemic hyperparathyroidism: a clinical study.
Topics: Adolescent; Adult; Aged; Aluminum Hydroxide; Calcitriol; Calcium Carbonate; Chronic Kidney Disease-Mineral and Bone Disorder; Follow-Up Studies; Hospitals, University; Humans; Middle Aged; Parathyroidectomy; Postoperative Complications; Quality of Life; Radiography; Scotland; Treatment Outcome | 1992 |
Reduced risk of hypercalcemia for hemodialysis patients by administering calcitriol at night.
Topics: Acetates; Acetic Acid; Aged; Calcitriol; Calcium; Calcium Carbonate; Chronic Kidney Disease-Mineral and Bone Disorder; Circadian Rhythm; Female; Humans; Hypercalcemia; Male; Middle Aged; Phosphates; Renal Dialysis; Risk Factors; Time Factors | 1992 |
Efficacy of calcium carbonate and low-dose vitamin D/1,25(OH)2D3 in reducing the risk of developing renal osteodystrophy in children on continuous ambulatory peritoneal dialysis.
Topics: Administration, Oral; Adolescent; Adult; Alkaline Phosphatase; Blood Urea Nitrogen; Bone and Bones; Calcitriol; Calcium Carbonate; Child; Child, Preschool; Chronic Kidney Disease-Mineral and Bone Disorder; Humans; Hypercalcemia; Infant; Parathyroid Glands; Peritoneal Dialysis, Continuous Ambulatory; Vitamin D; Water-Electrolyte Balance | 1990 |
Renal osteodystrophy in patients on continuous ambulatory peritoneal dialysis.
Topics: Adolescent; Calcium Carbonate; Child; Child, Preschool; Chronic Kidney Disease-Mineral and Bone Disorder; Drug Therapy, Combination; Female; Humans; Hydroxycholecalciferols; Infant; Kidney Failure, Chronic; Male; Peritoneal Dialysis, Continuous Ambulatory; Rickets | 1990 |
Treatment and prevention of uremic osteodystrophy.
Topics: Amino Acids, Essential; Calcium Carbonate; Chronic Kidney Disease-Mineral and Bone Disorder; Diet, Vegetarian; Dietary Proteins; Food, Fortified; Humans; Kidney Failure, Chronic; Phosphorus; Renal Dialysis | 1989 |
[High doses of calcium carbonate or the combination of 1 alpha hydroxylated derivatives of vitamin D and aluminum compounds bound to phosphorus in the preventive treatment of renal osteodystrophy].
Topics: Alum Compounds; Aluminum; Calcium Carbonate; Chronic Kidney Disease-Mineral and Bone Disorder; Humans; Magnesium; Osteomalacia; Phosphorus; Vitamin D | 1988 |
Preventing renal bone disease in moderate renal failure with CaCO3 and 25(OH) vitamin D3.
Topics: Calcifediol; Calcium; Calcium Carbonate; Chronic Kidney Disease-Mineral and Bone Disorder; Humans; Phosphates; Uremia | 1988 |
[The effects of CaCO3 on renal osteodystrophy--comparison of patients with chronic renal failure in the predialytic stage and patients undergoing maintenance hemodialysis].
Topics: Aged; Calcium; Calcium Carbonate; Chronic Kidney Disease-Mineral and Bone Disorder; Humans; Kidney Failure, Chronic; Middle Aged; Renal Dialysis | 1988 |
Reversal of aluminum-related bone disease after substituting calcium carbonate for aluminum hydroxide.
Topics: Aged; Aluminum; Aluminum Hydroxide; Biopsy; Bone and Bones; Calcium Carbonate; Chronic Kidney Disease-Mineral and Bone Disorder; Humans; Male; Peritoneal Dialysis, Continuous Ambulatory | 1988 |
Bone turnover and 1,25-dihydroxycholecalciferol during treatment with phosphate binders.
Topics: Adolescent; Aluminum Hydroxide; Bone Resorption; Calcitriol; Calcium Carbonate; Child; Child, Preschool; Chronic Kidney Disease-Mineral and Bone Disorder; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Osteogenesis; Phosphates | 1988 |
The interaction of parathyroid hormone and aluminum in renal osteodystrophy.
Topics: Adult; Aluminum; Calcium Carbonate; Chronic Kidney Disease-Mineral and Bone Disorder; Deferoxamine; Humans; Male; Osteomalacia; Parathyroid Hormone; Phosphates; Renal Dialysis | 1987 |
Alternative phosphate binders in dialysis patients: calcium carbonate.
Topics: Aluminum; Calcium Carbonate; Chronic Kidney Disease-Mineral and Bone Disorder; Humans; Hyperparathyroidism; Kidney Failure, Chronic; Phosphates; Phosphorus; Renal Dialysis | 1986 |
Controlled study of renal osteodystrophy in patients undergoing dialysis. Improved response to continuous ambulatory peritoneal dialysis compared with hemodialysis.
Topics: Aluminum Hydroxide; Calcitriol; Calcium; Calcium Carbonate; Chronic Kidney Disease-Mineral and Bone Disorder; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Phosphorus; Renal Dialysis | 1987 |
Management of rachitic deformities in children with chronic renal failure.
Topics: Aluminum Hydroxide; Calcium Carbonate; Child; Chronic Kidney Disease-Mineral and Bone Disorder; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Hydroxycholecalciferols; Infant; Kidney Failure, Chronic; Male; Radiography; Time Factors | 1986 |
The influence of a high calcium carbonate intake on bone disease in patients undergoing hemodialysis.
Topics: Administration, Oral; Alkaline Phosphatase; Aluminum Hydroxide; Biopsy; Bone and Bones; Calcification, Physiologic; Calcium; Calcium Carbonate; Chronic Kidney Disease-Mineral and Bone Disorder; Follow-Up Studies; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Osteomalacia; Phosphorus; Radiography; Renal Dialysis | 1973 |